On September 11, 2023, the Food and Drug Administration (FDA) authorized and approved the updated 2023-24 formulations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine. The Advisory Committee on Immunization Practices (ACIP), which makes recommendations to the Centers for Disease Control and Prevention (CDC) for the use of immunizations, met on September 12, 2023, and voted on recommendations for the use of the updated 2023-24 formulations of Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine.
The iREACH team at AIM developed talking points to assist REACH recipients with these updated COVID-19 vaccine recommendations. Recipients can utilize this resource in conversations and resource development.
